Showing results (241-250 of 478) with videos related to

Sort By:
Pageof 48
Journal of Managed Care & Specialty Pharmacy|October 29, 2024
Dose escalation of biologics in biologic-naive patients with Crohn's disease: Outcomes from the ODESSA-CD studyNoa Krugliak Cleveland, Sabyasachi Ghosh, Niranjan Kathe, et al.
Eclinicalmedicine|March 29, 2024
Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn's disease: a prospective cohort studyMariangela Allocca, Cecilia Dell'Avalle, Alessandra Zilli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2020
An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDILeigh Anne Shafer, M Anthony Sofia, David T Rubin, et al.
Inflammatory Bowel Diseases|December 15, 2020
Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative ColitisSujaata Dwadasi, Maryam Zafer, Donald Goens, et al.
Inflammatory Bowel Diseases|February 15, 2023
Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 DataSilvio Danese, Jacinda Tran, Geert D'Haens, et al.
Journal of Crohn'S & Colitis|November 9, 2023
Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial ProgrammeTim Raine, Yoh Ishiguro, David T Rubin, et al.
The Journal of Rheumatology|November 16, 2021
Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based StudyJeffrey R Curtis, Xiaofeng Zhou, David T Rubin, et al.
Digestive Diseases and Sciences|February 23, 2018
Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative ColitisWing Yan Mak, Anthony Buisson, Michael J Andersen, et al.
Inflammatory Bowel Diseases|March 23, 2024
Continuous Monitoring of CRP, IL-6, and Calprotectin in Inflammatory Bowel Disease Using a Perspiration-Based Wearable DeviceSarah Shahub, Ruchita Mahesh Kumar, Kai-Chun Lin, et al.
Inflammatory Bowel Diseases|August 2, 2024
Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG StudyMiguel Regueiro, Monika Fischer, Peter Bossuyt, et al.
Pageof 48